CAC 40
8 167,50 -20,99 (-0,26 %) Euro Stoxx 50
5 064,14 -8,31 (-0,16 %) Dow Jones
40 003,59 +134,19 (+0,34 %) EUR/USD
1,0880 +0,0011 (+0,10 %) Gold future
2 419,80 +2,40 (+0,10 %) Bitcoin EUR
60 640,25 -871,66 (-1,42 %)
Medpace Holdings, Inc. (MEDP)
Échanges après Bourse :
Medpace Holdings, Inc.
5375 Medpace Way
Cincinnati, OH 45227
United States
513 579 9911
https://www.medpace.com
Secteur(s): Healthcare
Secteur d’activité: Diagnostics & Research
Employés à temps plein: 5 800
Dirigeants clés
| Nom | Titre | Payer | Exercé | Année de naissance |
|---|---|---|---|---|
| Dr. August James Troendle M.D. | Chairman & CEO | 1,65M | S.O. | 1956 |
| Mr. Jesse J. Geiger BBA, CPA | President | 945,08k | S.O. | 1974 |
| Mr. Kevin M. Brady | CFO & Treasurer | 690,48k | 1,64M | 1975 |
| Ms. Susan E. Burwig BSN, MA | Executive Vice President of Operations | 1,12M | 1,47M | 1963 |
| Mr. Stephen P. Ewald J.D. | Chief Compliance Officer, General Counsel & Corporate Secretary | 914,64k | 3,2M | 1969 |
| Brandon Ebken | Chief Information Officer | S.O. | S.O. | S.O. |
| Ms. Lauren Morris | Associate Director of Investors Relations | S.O. | S.O. | S.O. |
| Mr. Todd Meyers | Vice President of Business Development & Marketing | S.O. | S.O. | S.O. |
| John T. Wynne MBA | Senior Vice President of Commercial Operations & Clinical Pharmacology Unit | S.O. | S.O. | S.O. |
| Mr. Reinilde Heyrman M.D. | Chief Medical Officer of Medical Department | S.O. | S.O. | 1961 |
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Gouvernance d’entreprise
L’ISS Governance QualityScore de Medpace Holdings, Inc. en date du 1 mai 2024 est 6. Les scores principaux sont Audit : 4; Société : 9; Droits des actionnaires : 8; Compensation : 4.
